Enveric Biosciences, Inc. funding
Enveric Biosciences, Inc., a biotechnology company based in Cambridge, MA, filed a Form D with the SEC on May 4, 2026 and reported $5M raised. It filed 3 new offerings in this period, totaling $6.6M.
Amount raised$5M
Offering size$5M
Filed with the SECMay 4, 2026
First saleApril 17, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants
LocationCambridge, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far4
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed May 4
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| May 4, 2026 | $5M | $5M | Equity, Options or warrants |
| February 11, 2026 | $1.5M | $1.5M | Options or warrants |
| December 23, 2025 | $107K | $107K | Options or warrants |
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care